One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Compare complete versions: U.S. labeling uses 2-hour infusions, while UCSF uses 3-hour extended infusions. Nebraska separately lists an HD/PD interval different from the label. Do not select a dose from one version and an interval from another.
Adult labeled cIAI, cUTI/pyelonephritis and HABP/VABP dosing uses total combination grams, all infused IV over 2 hours.
| Cockcroft-Gault CrCl (mL/min) | Dose | Interval |
|---|---|---|
| >50 | 2.5 g | Every 8 hours |
| 31-50 | 1.25 g | Every 8 hours |
| 16-30 | 0.94 g | Every 12 hours |
| 6-15 | 0.94 g | Every 24 hours |
| <=5 | 0.94 g | Every 48 hours |
On HD days, administer after dialysis. For changing renal function, reassess clearance at least daily. Adult cIAI treatment also includes metronidazole. This label's 2-hour infusion differs from the UCSF 3-hour strategy; its <=5 band also resolves a boundary omitted by that institutional page. Pediatric dosing requires a separate age/eGFR table, not this adult table.
RDM30-067-ceftazidime-avibactam-1 · Source locator: AVYCAZ - adult U.S. label renal table; renal/dosing sections and stated qualifiers
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=ceftazidime-avibactam&s1=RDM30-067-ceftazidime-avibactam&h1=8c58a54f5e36fdcf9c5d0a79fce691a92fb667af4b9472bbd4698bedfcaa2661